Cooperative AgreementPostedDiscretionary

Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2

National Institutes of Health
RFA-DA-28-001
Application Deadline
—
Days Remaining
—
Until deadline
Award Ceiling
$1,000,000
Total Program Funding
$5,000,000

Grant Opportunity Analysis

The National Institutes of Health and the National Institute on Drug Abuse seek applications to fund Phase 2 of the Single Cell Opioid Responses in the Context of HIV (SCORCH) Program. Funded projects must perform research that addresses critical questions on Substance Use Disorder and its interactions with HIV disease progression at the subcellular, cellular, or circuit levels in the central nervous system. Work will leverage cutting-edge single cell approaches and data mining to identify candidate mechanisms, targets, and functional significance to advance the mechanistic understanding of these interactions. Eligible applicants include regional organizations, faith-based or community-based organizations, territorial governments, and eligible federal agencies. The program has an estimated total funding of $5,000,000 to support approximately eight awards, and inquiries should be directed to NIDA_GED_Program@nida.nih.gov.

Eligible Applicants

Others
Additional Eligibility Information

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;

Grant Documents

0 Files
No grant documents

No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedAug 20, 2026

Funding Details

Award Ceiling
$1,000,000
Est. Total Program Funding
$5,000,000
Expected Awards
8
No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

Name
National Institute on Drug Abuse (NIDA)

CFDA Numbers

93.279

Official Sources